Investigation of the Novel Lead of Melanocortin 1 Receptor for Pigmentary Disorders

<table>Ligand and C-alpha solvent accessible surface (SAS). The control ligand had larger SAS value compared with other ligands, but its corresponding complex was almost consistent to other complexes.</table>

Evidence-Based Complementary and Alternative Medicine

fig9

Figure 9

Figure 9: Investigation of the Novel Lead of Melanocortin 1 Receptor for Pigmentary Disorders 